title: [Large cell lymphomas: effect of histologic groups on the prognosis. Study of 210 cases treated with the same therapeutic protocols].
abstract: As part of a study of two therapeutic protocols initiated in 1982 and 1985, respectively, for localized (n = 134) and disseminated (n = 76) large cell lymphomas, histologic type was determined for each patient by several pathologists using the Kiel classification for morphologic features and the international working formulation for protocol assignment and multifactorial statistical analysis. Therapeutic results in the two hundred and ten cases were correlated with a number of prognostic factors including age, stage, tumor size, extranodal disease, and clinical or biological markers for disease activity such as the LDH level. The previously reported influence of histologic subgroup on prognosis was not found with these highly effective protocols, whether histologic type was considered alone or in combination with other prognostic factors. The only consistent finding was that anaplastic large cell lymphomas, despite their aggressive features, were most likely to have a favorable outcome.
authors.affiliation: Service d'Histopathologie et Unité de Biostatistiques, Institut Curie, Paris.
authors.forename: J
authors.initials: J
authors.lastname: Dumont
authors.forename: P
authors.initials: P
authors.lastname: Charpy-Validire
authors.forename: M
authors.initials: M
authors.lastname: Raphael
authors.forename: M
authors.initials: M
authors.lastname: Tulliez
authors.forename: V
authors.initials: V
authors.lastname: Le Doussal
authors.forename: J
authors.initials: J
authors.lastname: Barge
authors.forename: V
authors.initials: V
authors.lastname: Mosseri
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D016403:Lymphoma, Large B-Cell, Diffuse / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D016400:Lymphoma, Large-Cell, Immunoblastic / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis
vernacular_title: Lymphomes à grandes cellules: influence des groupes histologiques sur le pronostic. Etude de 210 cas soumis aux mêmes protocoles thérapeutiques.